Search Results 71-80 of 16896 for Hodgkin disease
Also, to compare the PFS of a standard chemotherapy approach versus an IO therapy approach (brentuximab vedotin and nivolumab) plus involved site radiation ...
This pilot clinical trial studies Salvia hispanica seed in reducing the risk of returning disease (recurrence) in patients with non-Hodgkin lymphoma. Functional ...
... Hodgkin lymphoma, and about 20,000 Americans die from the disease each year. Among non-Hodgkin lymphomas, the most common is diffuse large B-cell lymphoma ...
For example, a patient with Hodgkin lymphoma may have a mass develop as part of the disease. He or she can undergo chemotherapy that puts the disease into ...
This pilot clinical trial studies how well buparlisib works in treating patients with non-Hodgkin lymphoma that has returned or does not respond to treatment.
Dr. Cerhan's Lymphoma Epidemiology Lab at Mayo Clinic coordinates the LEO cohort study of unmet health needs for patients with non-Hodgkin lymphoma.
Non-Hodgkin's lymphoma · Cutaneous T-cell lymphoma; Castleman disease. Request an appointment. May 09, 2023. Print.
Reduced Dose Hypofractionated Radiotherapy For Indolent Non-hodgkin Lymphoma ... Participant eligibility includes age, gender, type and stage of disease, and ...
The purpose of this study is to evaluate oral LOXO-305 in patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) or Non-Hodgkin ...
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Relapse in Aggressive B-cell Non-Hodgkin Lymphomas ... Hodgkin lymphoma. The purpose ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.